Skip to content

Diabetes Journey: An Adolescent Adherence Barriers Intervention

Diabetes Journey: An Intervention to Improve Adherence Barriers for Adolescents With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04404556
Enrollment
195
Registered
2020-05-27
Start date
2020-08-10
Completion date
2024-03-31
Last updated
2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Patient, Type 1 Diabetes

Keywords

Adolescent, mHealth, executive functioning skills, adherence barriers

Brief summary

The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a web-based intervention addressing adherence barriers in adolescents with T1D.

Detailed description

Type 1 diabetes (T1D) treatment adherence is complex and involves glucose monitoring, counting carbohydrates, and intensive insulin delivery via injections or insulin pump in response to food intake, exercise, and illness to achieve near-normal blood glucose levels. Evidence demonstrates that adhering to T1D treatment is challenging, especially during adolescence. Non-adherence leads to suboptimal glycemic levels that severely compromise health and quality of life. Suboptimal adherence to T1D treatment regimen is common in \>50% of adolescents and directly related to suboptimal glycemic control, increased risk of hospitalizations for diabetic ketoacidosis, and decreased health-related quality of life (HRQOL). The maximum benefits of current diabetes technology are limited by the knowledge, skills, adherence barriers, and non-adherence behaviors.10-14 Ultimately, adolescents have to overcome these barriers in order to benefit from technological advances. Thus, there is a clear need for behaviorally focused interventions to identify and reduce adherence barriers. The overall objective of this study is to identify adolescents with elevated adherence barriers and provide novel tailored mHealth intervention (Diabetes Journey) targeting these barriers. This study is two phases and includes a small pilot of up to 12 adolescents with type 1 diabetes (Phase 1) and a randomized controlled clinical trial (Phase 2). The randomized controlled clinical trial will examine feasibility, acceptability and preliminary efficacy of Diabetes Journey versus enhanced standard of care (control group) in approximately 256 adolescents with type 1 diabetes. Primary and secondary outcomes include adherence barriers, adherence, health-related quality of life and A1C. Satisfaction and acceptability will also be examined. Mediators and moderators will include executive functioning, diabetes distress, family conflict, depressive symptoms, fear of hypoglycemia and sleep.

Interventions

BEHAVIORALDiabetes Journey

Web-based telehealth intervention focused on adherence barriers and problem-solving

BEHAVIORALEnhanced Standard of Care

General education via the T1DToolkit website, as well as 4 phone calls with certified diabetes educators (CDEs) will be provided.

Sponsors

University of Florida
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Colorado, Denver
CollaboratorOTHER
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Masking description

Outcome measures are patient-reported and thus masking will not occur at the level of participant, investigator or outcomes assessor.

Intervention model description

Participants will be randomized to one of two conditions: 1) Diabetes Journey or 2) Enhanced Standard of Care.

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* T1D diagnosis \>1 year * Adolescents with T1D ages 13-17 * Elevations on the Barriers to Diabetes Adherence questionnaire (scores of ≥3 of 53 for the Stress/Burnout and/or Time Pressure/Planning subscales) based on their previous clinic visit scores * Ability to read/speak English (all measures are in English)

Exclusion criteria

* Diagnosis of significant developmental disorders (e.g., autism spectrum disorder, moderate/severe developmental or intellectual disability) * Comorbid medical diagnoses (e.g., cystic fibrosis, asthma) with the exception of endocrine disorders (e.g., Celiac disease, thyroid) * No use of/plans to use non-insulin medication for blood glucose control

Design outcomes

Primary

MeasureTime frameDescription
Barriers to Diabetes Adherence Questionnaire-Youth Report Stress/Burnout Subscale6-month follow-upStress and Burnout Scale - assesses frustration and feeling burned out by diabetes and its management. Score range from 1-5, with higher scores representing greater barriers.
Barriers to Diabetes Adherence Questionnaire - Youth Report Time Pressure/Planning Subscale6-month follow-upTime Pressure and Planning Subscale - assesses the time and energy it takes to plan for diabetes self-management, including carrying supplies and making management decisions. Score range from 1-5, with higher scores representing greater barriers.

Secondary

MeasureTime frameDescription
Adherence for Continuous Glucose Monitors6-month follow-up% Time in Range for those on continuous glucose monitors.
Adherence6-month follow-up\# blood glucose checks per day
Hemoglobin A1C6-month follow-upA blood test that measures the average blood sugar levels over the past two to three months.
Adherence to Insulin Boluses6-month follow-upThe average of the frequency of insulin boluses delivered per day
Adherence for Insulin Pump Users6-month follow-up\# carbohydrate entries per day for insulin pump users
Type 1 Diabetes and Life -Youth Report6-month follow-upTotal Quality of Life Scores range from 0-100, with higher scores indicating better quality of life

Countries

United States

Participant flow

Pre-assignment details

After participants were consented, there was a screening process. If participants were elevated on the BDA, they were eligible to be randomized. If they were not elevated, they screen failed. Of the 195 participants who were consented, n=13 screen failed and additional n=20 withdrew prior to randomization. Thus, only n=162 were randomized.

Participants by arm

ArmCount
Diabetes Journey
Diabetes Journey is a web-based intervention to address key adherence barriers. Participants randomized to this arm will first receive the mandatory Introduction and Problem-Solving Module. Based on their elevations on the Barriers to Diabetes Adherence measure, participants will receive up to 7 modules in total. Participants will navigate through the web-based theme park map and complete modules independently and then will have accompanying Zoom telehealth sessions with a therapist. Diabetes Journey: Web-based telehealth intervention focused on adherence barriers and problem-solving
97
Enhanced Standard of Care
Participants randomized to Enhanced Standard of Care will receive general education via the T1DToolkit website, as well as 4 phone calls with certified diabetes educators (CDEs) from each site across 12-weeks. Content to address adherence barriers were modified and or newly developed for the Enhanced Standard of Care group via the T1DToolkit website. Enhanced Standard of Care: General education via the T1DToolkit website, as well as 4 phone calls with certified diabetes educators (CDEs) will be provided.
65
Total162

Withdrawals & dropouts

PeriodReasonFG000FG001
Follow-up 1Missing Data47
Follow-up 1Withdrawal by Subject51
Follow-up 2Missing Data65
Follow-up 2Withdrawal by Subject11
InterventionDid not complete all intervention sessions21
InterventionWithdrawal by Subject153
Post-InterventionMissing Data12

Baseline characteristics

CharacteristicEnhanced Standard of CareTotalDiabetes Journey
Age, Continuous14.74 years
STANDARD_DEVIATION 1.72
14.79 years
STANDARD_DEVIATION 1.58
14.82 years
STANDARD_DEVIATION 1.49
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants14 Participants6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
57 Participants148 Participants91 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
3 Participants8 Participants5 Participants
Race (NIH/OMB)
More than one race
5 Participants10 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
White
56 Participants142 Participants86 Participants
Sex: Female, Male
Female
37 Participants93 Participants56 Participants
Sex: Female, Male
Male
28 Participants69 Participants41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 970 / 65
other
Total, other adverse events
50 / 9739 / 65
serious
Total, serious adverse events
0 / 971 / 65

Outcome results

Primary

Barriers to Diabetes Adherence Questionnaire-Youth Report Stress/Burnout Subscale

Stress and Burnout Scale - assesses frustration and feeling burned out by diabetes and its management. Score range from 1-5, with higher scores representing greater barriers.

Time frame: 6-month follow-up

ArmMeasureValue (MEAN)Dispersion
Diabetes JourneyBarriers to Diabetes Adherence Questionnaire-Youth Report Stress/Burnout Subscale2.36 score on a scaleStandard Deviation 0.9
Enhanced Standard of CareBarriers to Diabetes Adherence Questionnaire-Youth Report Stress/Burnout Subscale2.31 score on a scaleStandard Deviation 1.05
Primary

Barriers to Diabetes Adherence Questionnaire - Youth Report Time Pressure/Planning Subscale

Time Pressure and Planning Subscale - assesses the time and energy it takes to plan for diabetes self-management, including carrying supplies and making management decisions. Score range from 1-5, with higher scores representing greater barriers.

Time frame: 6-month follow-up

ArmMeasureValue (MEAN)Dispersion
Diabetes JourneyBarriers to Diabetes Adherence Questionnaire - Youth Report Time Pressure/Planning Subscale1.92 score on a scaleStandard Deviation 0.58
Enhanced Standard of CareBarriers to Diabetes Adherence Questionnaire - Youth Report Time Pressure/Planning Subscale2.03 score on a scaleStandard Deviation 0.89
Secondary

Adherence

\# blood glucose checks per day

Time frame: 6-month follow-up

Secondary

Adherence for Continuous Glucose Monitors

% Time in Range for those on continuous glucose monitors.

Time frame: 6-month follow-up

Secondary

Adherence for Insulin Pump Users

\# carbohydrate entries per day for insulin pump users

Time frame: 6-month follow-up

Secondary

Adherence to Insulin Boluses

The average of the frequency of insulin boluses delivered per day

Time frame: 6-month follow-up

Secondary

Hemoglobin A1C

A blood test that measures the average blood sugar levels over the past two to three months.

Time frame: 6-month follow-up

ArmMeasureValue (MEAN)Dispersion
Diabetes JourneyHemoglobin A1C8.06 percentage of glycosylated hemoglobinStandard Deviation 1.72
Enhanced Standard of CareHemoglobin A1C7.98 percentage of glycosylated hemoglobinStandard Deviation 1.67
Secondary

Type 1 Diabetes and Life -Youth Report

Total Quality of Life Scores range from 0-100, with higher scores indicating better quality of life

Time frame: 6-month follow-up

ArmMeasureValue (MEAN)Dispersion
Diabetes JourneyType 1 Diabetes and Life -Youth Report65.84 score on a scaleStandard Deviation 14.71
Enhanced Standard of CareType 1 Diabetes and Life -Youth Report65.82 score on a scaleStandard Deviation 18.32

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026